We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KB:NYSEKB Financial Group Inc Analysis

Data as of 2026-08-25 - not real-time

$118.72

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind KB Financial Group Inc. is bullish at $118.72, with short-term averages leading the long-term ones. Across the trailing 30 sessions it lost 3.7%. Relative strength is 52.1 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $111.50 and resistance around $125.66.
On valuation the read is undervalued — earnings multiple of 9.7 versus a 17.0 sector average, below the peer group. Analyst price targets sit 50.1% above the current price. Revenue is growing at 18.5% on a 36.5% profit margin. The 2.64% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 39.4%, a beta of 1.46 and a maximum drawdown of 17.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.

Top Market Events

KB Financial Group Inc KB reports a 13.1% increase in net profit and surpasses KRW10 trillion in operating income,...South Korea's KB Financial Group posted record profits during the first half of this year, thanks to solid performances...KB Financial Group delivers record half-year profit as nonbank units surge

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 102.59
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 9.7 versus sector average of 17.0
  • Trading above the 200-day average of 102.59

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 9.7 versus sector average of 17.0
  • Analyst targets imply +50.1% versus the current price
  • Profit margin of 36.5% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth18.50%
Profit Margin36.53%
P/E Ratio9.7
ROE10.22%
ROA0.77%
P/B Ratio4.1
Op. Cash Flow$-29337826885632
Industry P/E17.0

Technical Analysis

TrendBullish
RSI52.1
Support$111.50
Resistance$125.66
MA 20$118.60
MA 50$114.93
MA 200$102.59
MACDBearish
VolumeDecreasing
Fear & Greed Index93.23

Valuation

Target Price$178.25
Upside/Downside50.14%
GradeUndervalued
TypeBlend
Dividend Yield2.64%

Risk Assessment

Beta1.46
Volatility39.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.